Eagle Asset Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-51,775
Closed -$3.13M 637
2017
Q2
$3.13M Sell
51,775
-576,025
-92% -$34.1M 0.02% 486
2017
Q1
$43.6M Sell
627,800
-43,181
-6% -$3M 0.27% 116
2016
Q4
$44.7M Sell
670,981
-73,693
-10% -$4.79M 0.29% 109
2016
Q3
$49.3M Buy
744,674
+4,660
+0.6% +$319K 0.33% 93
2016
Q2
$53.6M Sell
740,014
-34,927
-5% -$2.4M 0.37% 80
2016
Q1
$50.1M Sell
774,941
-72,994
-9% -$4.84M 0.35% 92
2015
Q4
$60.8M Sell
847,935
-90,296
-10% -$6.68M 0.41% 78
2015
Q3
$72M Sell
938,231
-187,532
-17% -$15.1M 0.49% 49
2015
Q2
$83.4M Sell
1,125,763
-88,450
-7% -$6.37M 0.47% 61
2015
Q1
$88M Sell
1,214,213
-95,519
-7% -$6.64M 0.5% 54
2014
Q4
$86.6M Sell
1,309,732
-31,618
-2% -$1.93M 0.5% 56
2014
Q3
$73.5M Buy
1,341,350
+125,338
+10% +$7.11M 0.42% 79
2014
Q2
$70.7M Buy
1,216,012
+186,357
+18% +$11M 0.38% 88
2014
Q1
$63.8M Buy
1,029,655
+49,409
+5% +$2.87M 0.35% 84
2013
Q4
$52.3M Buy
980,246
+198,440
+25% +$10.6M 0.29% 118
2013
Q3
$39M Buy
781,806
+222,596
+40% +$10.9M 0.19% 152
2013
Q2
$25.6M Buy
+559,210
New +$25M 0.17% 182

Other funds holding MD

Eagle Asset Management's MD Position: Q3 2017 in Review

Eagle Asset Management sold out of Pediatrix Medical (MD) in Q3 2017, closing a stake of 51,775 shares — an estimated $3.13M sold.

Eagle Asset Management first reported a position in MD in Q2 2013 and held it in 17 quarters. The position peaked at $88M in Q1 2015. 337 funds tracked by Wall St. Rank hold MD as of Q3 2017.

  • Eagle Asset Management reported no remaining Pediatrix Medical position as of Q3 2017 after selling out during the quarter.
  • Eagle Asset Management sold 51,775 Pediatrix Medical shares in Q3 2017, an estimated $3.13M.
  • Eagle Asset Management first reported a position in Pediatrix Medical in Q2 2013 and held it in 17 quarters.
  • Eagle Asset Management's Pediatrix Medical position peaked at $88M in Q1 2015.
  • 337 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2017.

Based on Eagle Asset Management's 13F filing for Q3 2017, filed 9 Nov 2017.